2172 related articles for article (PubMed ID: 8018377)
1. Mouse subrenal capsule assay chemosensitivity and DNA flow cytometry parameters of human melanoma metastases.
Muhonen T; Pyrhönen S; Laasonen A; Wasenius VM; Asko-Seljavaara S; Franssila K; Kangas L
Acta Oncol; 1994; 33(4):431-7. PubMed ID: 8018377
[TBL] [Abstract][Full Text] [Related]
2. Chemosensitivity of human melanoma metastases in mouse subrenal capsule assay--can it predict tumour response to combined cytostatic plus interferon therapy in metastatic melanoma?
Hahka-Kemppinen M; Muhonen T; Kangas L; Pyrhönen S
Melanoma Res; 1996 Jun; 6(3):215-21. PubMed ID: 8819124
[TBL] [Abstract][Full Text] [Related]
3. DNA flow cytometry and the outcome of chemoimmunotherapy in metastatic melanoma.
Hahka-Kemppinen M; Muhonen T; Nordling S; Pyrhönen S
Melanoma Res; 1997 Aug; 7(4):329-34. PubMed ID: 9293483
[TBL] [Abstract][Full Text] [Related]
4. Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma.
Muhonen T; Pyrhönen S; Laasonen A; Wasenius VM; Asko-Seljavaara S; Franssila K; Kangas L
Br J Cancer; 1992 Sep; 66(3):528-32. PubMed ID: 1520590
[TBL] [Abstract][Full Text] [Related]
5. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
Mäenpää J; Kangas L; Grönroos M
Obstet Gynecol; 1985 Nov; 66(5):708-13. PubMed ID: 3932908
[TBL] [Abstract][Full Text] [Related]
6. Chemohormone therapy of metastatic melanoma with megestrol acetate plus dacarbazine, carmustine, and cisplatin.
Nathanson L; Meelu MA; Losada R
Cancer; 1994 Jan; 73(1):98-102. PubMed ID: 8275444
[TBL] [Abstract][Full Text] [Related]
7. Subrenal capsule assay as a test to predict the effectiveness of chemotherapy in choriocarcinoma.
Ogino M; Sakamoto T; Yamamoto T; Mori H; Okinaga S; Arai K
Gynecol Oncol; 1990 Jul; 38(1):32-6. PubMed ID: 2354824
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.
Del Prete SA; Maurer LH; O'Donnell J; Forcier RJ; LeMarbre P
Cancer Treat Rep; 1984 Nov; 68(11):1403-5. PubMed ID: 6541973
[No Abstract] [Full Text] [Related]
9. Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.
Fierro MT; Bertero M; Novelli M; Appino A; Doveil GC; Colonna S; Bernengo MG
Melanoma Res; 1993 Apr; 3(2):127-31. PubMed ID: 8518551
[TBL] [Abstract][Full Text] [Related]
10. [Clinical application of subrenal capsule assay in ovarian cancer].
Maeda K; Ushijima H; Shimamoto T; Shigematsu T; Kurano A; Watanabe Y; Jimi S; Okadome M; Mashiba H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1896-902. PubMed ID: 2592813
[TBL] [Abstract][Full Text] [Related]
11. Bleomycin, carmustine, vincristine, and dacarbazine in patients with metastatic malignant melanoma.
Cohen SM; Ohnuma T; Cheung T; Holland JF
Cancer Treat Rep; 1983 Oct; 67(10):947-8. PubMed ID: 6194881
[No Abstract] [Full Text] [Related]
12. The subrenal capsule assay in selecting chemotherapy for ovarian cancer: a prospective randomized trial.
Mäenpää JU; Heinonen E; Hinkka SM; Karnani P; Klemi PJ; Korpijaakko TA; Kuoppala TA; Laine AM; Lähde MA; Nuoranne EK
Gynecol Oncol; 1995 Jun; 57(3):294-8. PubMed ID: 7774832
[TBL] [Abstract][Full Text] [Related]
13. Concordance of combination and single agent chemosensitivity prediction in ovarian carcinoma using the subrenal capsule xenograft assay (SRCA).
Stratton JA; Rettenmaier MA; Kucera PR; Berman ML; DiSaia PJ
Gynecol Oncol; 1988 Jul; 30(3):416-21. PubMed ID: 3391423
[TBL] [Abstract][Full Text] [Related]
14. Treatment of stage IV malignant melanoma with dacarbazine, carmustine, cisplatin, and tamoxifen regimens: a University of South Florida and H. Lee Moffitt Melanoma Center Study.
Saba HI; Cruse CW; Wells KE; Klein CJ; Reintgen DS
Ann Plast Surg; 1992 Jan; 28(1):65-9. PubMed ID: 1642409
[TBL] [Abstract][Full Text] [Related]
15. Growth of human colorectal carcinoma implants in the mouse subrenal capsule assay.
Kouri M; Pyrhönen S; Kangas L; Laasonen A; Franssila K; Mecklin JP; Turunen MJ; Lempinen M
Ann Chir Gynaecol; 1989; 78(2):110-4. PubMed ID: 2802490
[TBL] [Abstract][Full Text] [Related]
16. [Subrenal capsule assay using nude mice].
Kikuchi H; Asamura M; Gamoh M; Ohuchi H; Wakui A
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):532-41. PubMed ID: 2321981
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced and recurrent endometrial carcinoma: correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay.
Stratton JA; Mannel RS; Rettenmaier MA; Berman ML; DiSaia PJ
Gynecol Oncol; 1989 Jan; 32(1):55-9. PubMed ID: 2535831
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy of metastatic melanoma.
Berd D; Mastrangelo MJ
J Clin Oncol; 1995 Mar; 13(3):796-7. PubMed ID: 7884439
[No Abstract] [Full Text] [Related]
19. Adjuvant chemotherapy in malignant melanoma using dacarbazine, carmustine, cisplatin, and tamoxifen: a University of South Florida and H. Lee Moffitt Melanoma Center Study.
Saba HI; Cruse CW; Wells KE; Klein CJ; Reintgen DS
Ann Plast Surg; 1992 Jan; 28(1):60-4. PubMed ID: 1642408
[TBL] [Abstract][Full Text] [Related]
20. Subrenal capsule assay in selection of chemotherapy after operation for recurrent ovarian cancer.
Venesmaa P; Ylikorkala O
Br J Cancer; 1991 Jan; 63(1):84-6. PubMed ID: 1899195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]